121 Recruiting Gastric Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
π Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Gastric Cancer
Related Conditions
Top Recruiting Gastric Cancer Studies
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
π Mayo Clinic β Scottsdale, Arizona
View Study & Checklist βStudy to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
π USC Norris Comp. Cancer Ctr Hospital β Los Angeles, California
View Study & Checklist βPh1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
π Research Site β Baltimore, Maryland
View Study & Checklist βNivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
π Johns Hopkins University β Baltimore, Maryland
View Study & Checklist βStudy for AZD4360 in Participants With Advanced Solid Tumours
π Research Site β Santa Monica, California
View Study & Checklist βClaudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma
π Moffitt Cancer Center β Tampa, Florida
View Study & Checklist βAdoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
π UPMC Hillman Cancer Center β Pittsburgh, Pennsylvania
View Study & Checklist βA Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
π Memorial Sloan Kettering Basking Ridge (All Protocol Activities) β Basking Ridge, New Jersey
View Study & Checklist βNovel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
π Mayo Clinic- Minnesota β Rochester, Minnesota
View Study & Checklist βStudy of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
π Chao Family Comprehensive Cancer Center, University of California, Irvine β Orange, California
View Study & Checklist βA Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
π The Oncology Institute of Hope & Innovation β Anaheim, California
View Study & Checklist βTrial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
π Calvary Mater Newcastle β Newcastle, New South Wales
View Study & Checklist βAZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
π Research Site β Mobile, Alabama
View Study & Checklist βClaudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers
π City of Hope β Duarte, California
View Study & Checklist βThe Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.
π City of Hope β Duarte, California
View Study & Checklist βTotal Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
π UCLA β Los Angeles, California
View Study & Checklist βStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
π Research Site β Jacksonville, Florida
View Study & Checklist βCabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
π University of Kansas Cancer Center β Westwood, Kansas
View Study & Checklist βStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
π Yale Cancer Center β New Haven, Connecticut
View Study & Checklist βSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
π Research Site β Mobile, Alabama
View Study & Checklist βPhase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
π University of Chicago β Chicago, Illinois
View Study & Checklist βScreening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
π A.C.Camargo Cancer Center β SΓ£o Paulo,
View Study & Checklist βOral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy
π FundaciΓ³n CTIC - Centro de Tratamiento e InvestigaciΓ³n sobre CΓ‘ncer Luis Carlos Sarmiento Angulo β BogotΓ‘, Bogota D.C.
View Study & Checklist βSurgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
π National Institutes of Health Clinical Center β Bethesda, Maryland
View Study & Checklist βKK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
π Rutgers Cancer Institute β New Brunswick, New Jersey
View Study & Checklist βCA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
π Washington University School of Medicine β St Louis, Missouri
View Study & Checklist βAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
π Research Site β Orange, California
View Study & Checklist βPhase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
π NEXT Virginia β Fairfax, Virginia
View Study & Checklist βNovel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
π Research Site β Los Angeles, California
View Study & Checklist βDetection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers
π City of Hope Medical Center β Duarte, California
View Study & Checklist βAvutometinib and Defactinib in Diffuse Gastric Cancer
π Columbia University Irving Medical Center β New York, New York
View Study & Checklist βResilience and Equity in Aging, Cancer, and Health (REACH)
π Dana-Farber Cancer Institute β Boston, Massachusetts
View Study & Checklist βNeratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
π Stanford Cancer Center β Palo Alto, California
View Study & Checklist βCONFIRM: Magnetic Resonance Guided Radiation Therapy
π Brigham & Women's Hospital β Boston, Massachusetts
View Study & Checklist βAlternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
π City of Hope Medical Center β Duarte, California
View Study & Checklist βThe Gastric Cancer Foundation: A Gastric Cancer Registry
π Stanford University, School of Medicine β Stanford, California
View Study & Checklist βA Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
π Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) β Basking Ridge, New Jersey
View Study & Checklist βThe GAstric Precancerous Conditions Study
π Stanford University β Stanford, California
View Study & Checklist β